Evaluation of two different dosage regimens of clindamycin and the penetration into human appendix. 1989

A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
School of Pharmacy, University of Southern California, Los Angeles County.

The study objective was to evaluate serum, peritoneal fluid, and appendix tissue concentrations of clindamycin using two differing clindamycin regimens. Patients age 16 years and older who were about to undergo appendectomies were randomly assigned to receive gentamicin 1.5 mg/kg every 8 h admixed with clindamycin 900 mg every 8 h (8-h group) or clindamycin 600 mg every 6 h given separately (6-h group). Doses of each regimen were given preoperatively. Serum, peritoneal fluid, and appendix tissue samples were obtained intraoperatively, and frozen at -70 degrees C for gas chromatographic drug analysis. Twenty-one patients were evaluated, 11 patients in the 8-h group and 10 patients in the 6-h group. Values are reported as means +/- standard deviations. The values in the 8-h group were 12.3 +/- 14.1 micrograms/ml, 8.7 +/- 3.9 micrograms/ml, and 9.8 +/- 10.3 micrograms/g for serum, peritoneal fluid, and appendix tissue, respectively. The values in the 6-h group were 9.7 +/- 5.1 micrograms/ml, 5.8 +/- 5.3 micrograms/ml, and 6.2 +/- 4.9 micrograms/g for serum, peritoneal fluid, and appendix tissue, respectively. The 6-h group received more doses preoperatively (1.8 +/- 0.6) than the 8-h group (1.2 +/- 0.4; p less than 0.05). No differences in penetration of clindamycin into the serum, peritoneal fluid, and appendix tissue for the 8-h group and the 6-h group were noted. The study revealed a similarity in penetration of clindamycin into the serum, peritoneal fluid, and appendix tissue using either clindamycin 900 mg given by intermittent intravenous infusion every 8 h admixed with gentamicin or clindamycin 600 mg given every 6-h separately.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001065 Appendix A worm-like blind tube extension from the CECUM. Vermiform Appendix,Appendix, Vermiform

Related Publications

A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
September 1978, Archives of surgery (Chicago, Ill. : 1960),
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
May 1989, Antimicrobial agents and chemotherapy,
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
September 1987, American journal of hospital pharmacy,
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
January 1989, European journal of clinical pharmacology,
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
February 1976, Annals of internal medicine,
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
August 1980, Journal of the American Academy of Dermatology,
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
September 1978, Antimicrobial agents and chemotherapy,
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
January 1970, Clinical pharmacology and therapeutics,
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
October 2011, Veterinary dermatology,
A Chin, and M A Gill, and M K Ito, and A E Yellin, and T V Berne, and P N Heseltine, and M D Appleman, and F C Chenella
February 1978, Postgraduate medical journal,
Copied contents to your clipboard!